Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children

Journal of Clinical Ultrasound

Volumn 28, Issue 4, 2000, Pages 166-168

  Palanduz, Ayşe ^a,b   Yalçin, Işik ^a   Tonguç, Erdem ^a   Güler, Nermin ^a   Öneş, Ülker ^a   Salman, Nuran ^a   Somer, Ayper ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Fevzi Pasa Caddesi   (Turkey)

Author keywords

Ceftriaxone; Children; Gallbladder; Pseudolithiasis; Ultrasonography

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE;

ANTIBIOTIC THERAPY; ARTICLE; BILIARY TRACT DISEASE; CHILD; DIAGNOSTIC IMAGING; DRUG INDUCED DISEASE; ECHOGRAPHY; FEMALE; GALLBLADDER DISEASE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; ULTRASOUND;

ADOLESCENT; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; CHOLELITHIASIS; FEMALE; GALLBLADDER; HUMANS; INCIDENCE; INFANT; MALE; PRECIPITATION; PROSPECTIVE STUDIES; REMISSION, SPONTANEOUS;

EID: 0342657126     PISSN: 00912751     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0096(200005)28:4<166::AID-JCU2>3.0.CO;2-G     Document Type: Article

References (20)

1. Physicians desk reference. 51st edition. Montvale, NJ: Medical Economics; 1997. p 2305-2308.
2. Avidsson A, Alvan G, Angelin B, et al. Ceftriaxone: renal and biliary excretion and effect on colon microflora. J Antimicrob Chemother 1982;14:213.
3. Xia Y, Lambert KJ, Schteingart CD, et al. Concentrative biliary secretion of ceftriaxone. Inhibition of lipid secretion and precipitation of calcium ceftriaxone in bile. Gastroenterology 1990;99:454.
4. Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology 1990;99:1772.
5. Park HZ, Lee SP, Schy AL. Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology 1991;100:1665.
6. Lee SP, Lipsky BA, Teefey SA. Gallbladder sludge and antibiotics. Pediatr Infect Dis J 1990;9:422.
7. Schaad UB, Tschappeler H, Lentze MJ. Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy. Pediatr Infect Dis J 1986;5:708.
8. Jacobs RF. Ceftriaxone-associated cholecystitis. Pediatr Infect Dis J 1988;7:434.
9. Zinberg J, Chernaik R, Coman E, et al. Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis. Am J Gastroenterol 1991;86:1251.
10. Kirejczyk WM, Crowe HM, Mackay IM, et al. Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy. AJR Am J Roentgenol 1992;159:329.
11. Bonioli E, Bellini C, Toma P. Pseudolithiasis and intractable hiccups in a boy receiving ceftriaxone. N Engl J Med 1994;331:1532.
12. Lopez AJ, O'Keefe P, Morrissey M, et al. Ceftriax-one-induced cholelithiasis. Ann Intern Med 1991; 115:712.
13. Robertson FM, Crombleholme TM, Barlow SE, et al. Ceftriaxone choledocholithiasis. Pediatrics 1996;98:133.
14. Schaad UB, Wedgwood-Krucko J, Tschaeppeler H. Reversible ceftriaxone-associated biliary pseudolithiasis in children. Lancet 1988;2:1411.
15. Schaad UB, Suter S, Gianella-Borradori A, et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med 1990;322:141.
16. Schaad UB, Wedgwood J. Ceftriaxone versus cefuroxime for meningitis in children. N Engl J Med 1990;322:1821.
17. Pigrau C, Pahissa A, Gropper S, et al. Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet 1989;2:165.
18. Heim-Duthoy KL, Caperton EM, Pollock R, et al. Apparent biliary pseudolithiasis during ceftriax-one therapy. Antimicrob Agents Chemother 1990; 34:1146.
19. Billstein SA, Sudol TE. Ceftriaxone for pediatric patients with Lyme disease. J Infect Dis 1994;169: 937.
20. Kong MS, Chen CY. Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children. Chang Keng I Hsueh 1996;19:50.